Blocking protease-activated receptor 4 alleviates liver injury induced by brain death

Biochem Biophys Res Commun. 2022 Mar 5:595:47-53. doi: 10.1016/j.bbrc.2022.01.074. Epub 2022 Jan 21.

Abstract

Brain death (BD) induces a systemic inflammatory response that influences donor liver quality. Protease-activated receptor 4 (PAR4) is a thrombin receptor that mediates platelet activation and is involved in inflammatory and apoptotic processes. Therefore, we investigated the role of PAR4 blockade in liver injury induced by BD and its associated mechanisms. In this study, we constructed a BD rat model and treated rats with TcY-NH2, a selective PAR4 antagonist, to block PAR4 signaling at the onset of BD induction. Our results revealed that PAR4 protein expression increased in the livers of rats with BD. PAR4 blockade alleviated liver injury induced by BD, as indicated by lower serum ALT/AST levels and an improvement in histomorphology. Blood platelet activation and hepatic platelet accumulation in BD rats were reduced by PAR4 blockade. Additionally, PAR4 blockade attenuated the inflammatory response and apoptosis in the livers of BD rats. Moreover, the activation of NF-κB and MAPK pathways induced by BD was inhibited by PAR4 blockade. Thus, our results suggest that PAR4 contributes to liver injury induced by BD by regulating inflammation and apoptosis through the NF-κB and MAPK pathways. Thus, PAR4 blockade may provide a feasible approach to improve the quality of organs from BD donors.

Keywords: Apoptosis; Brain death; Inflammation; Liver injury; Protease-activated receptor 4.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Blotting, Western
  • Brain Death / metabolism*
  • Brain Death / physiopathology
  • Cytokines / genetics
  • Cytokines / metabolism
  • Gene Expression / drug effects
  • Inflammation / genetics
  • Inflammation / metabolism
  • Inflammation Mediators / metabolism
  • Liver / drug effects*
  • Liver / metabolism
  • Liver / pathology
  • MAP Kinase Signaling System / drug effects
  • Male
  • NF-kappa B / metabolism
  • Oligopeptides / pharmacology*
  • Platelet Activation / drug effects
  • Platelet Aggregation / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Thrombin / antagonists & inhibitors*
  • Receptors, Thrombin / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Cytokines
  • Inflammation Mediators
  • NF-kappa B
  • Oligopeptides
  • Receptors, Thrombin
  • cinnamoyl-tyrosyl-prolyl-glycyl-lysyl-phenylalaninamide
  • protease-activated receptor 4